Table 2.
Molecules involved in T cell migration through afferent LVs to dLNs.
Molecule | Comments | References |
---|---|---|
CCR7/CCL21 | In mice, Ccr7−/− T cells display a profound reduction in migration from peripheral tissues to dLNs. In humans, all recirculating memory T cell subtypes are CCR7+ |
[41] [147] |
S1P | Treatment with FTY720 reduced T cell migration to LNs Blocking of S1P1 and S1P4 reduce entry of Teff CD4+ into afferent LVs S1P2 in LECs regulates T cell motility and transmigration |
[82] [162] [162] |
CD44/Macrophage mannose receptor (MMR) | Interaction of MMR in LECs with CD44 in T cells mediates CD4+ and CD8+ egress from skin | [169,170] |
CLEVER-1 | CLEVER-1 blockade reduces CD4+ and CD8+ T cell migration from the skin to the dLN | [171,172] |
ICAM-1/VCAM-1 | T cells require LFA-1/ICAM-1 interactions promoting T cell crawling and overall migration through afferent LVs Treg migration to dLNs depends on VCAM-1 TH1 cell migration to dLNs depends on VCAM-1 |
[65] [65,152] |
Lymphotoxin (LT) | Blockade of LTBR that binds to VCAM-1 reduced Treg exit from the skin Treg modulate LECs for transmigration of other cells, by stimulating LEC LTBR, to increase VCAM-1 and CCL21 |
[48] |
CD69 | CD69 downregulates S1P1, thereby inhibiting T cell egress from skin Cd69-/- T cells can enter the skin but do not form a TRM population |
[166] [165] |
MECA-32 (PLVAP) | PLVAP expressed by LN LECs mediates lymphocyte entry across the subcapsular sinus into the LN parenchyma | [30] |